BLFS logo

BLFS

BioLife Solutions Inc.

$25.25
+$0.75(+3.06%)
60
Overall
60
Value
80
Tech
42
Quality
How is this score calculated?
Market Cap
$1.22B
Volume
540.99K
52W Range
$17.86 - $29.62
Target Price
$32.56
Order:

Income Statement

MetricTrendChart
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
2025
Dec
REVENUE
Total Revenue
$8.2M$11.0M$19.7M$27.4M$48.1M$119.2M$161.8M$75.9M$74.6M$96.2M
Total Revenue
$8.2M$11.0M$19.7M$27.4M$48.1M$119.2M$161.8M$75.9M$74.6M$96.2M
COST OF GOODS SOLD
Cost of Revenue
$-3.4M$-4.3M$-6.2M$8.4M$20.6M$82.1M$107.9M$96.5M$24.6M$34.1M
GROSS PROFIT
Gross Profit
$4.8M$6.7M$-6.2M$19.0M$27.4M$37.0M$53.8M$45.9M$50.1M$62.1M
OPERATING EXPENSES
Operating Expenses
$-9.6M$-7.8M$9.9M$18.8M$31.4M$69.3M$93.7M$71.6M$54.6M$63.2M
Research & Development
$2.0M$1.2M$1.3M$3.2M$6.7M$11.8M$14.8M$12.1M$4.8M$7.6M
Research Expense
$2.0M$1.2M$1.3M$3.2M$6.7M$11.8M$14.8M$12.1M$4.8M$7.6M
Selling, General & Administrative
$7.6M$6.6M$8.6M$13.6M$21.0M$47.7M$69.2M$56.0M$49.6M$55.4M
Selling & Marketing Expenses
$3.0M$2.1M$2.6M$4.7M$6.4M$14.0M$21.6M$12.7M$8.9M$9.8M
General & Administrative Expenses
$4.6M$4.5M$6.0M$8.9M$14.6M$33.7M$47.7M$43.3M$40.6M$45.5M
Promotion & Advertising
$-74.9K$-39.0K$-30.0K$43.0K$167.0K$552.0K--------
Salaries & Wages
$-777.0K$-1.3M$-1.5M$3.0M------------
Depreciation & Amortization
$218.4K$156.0K$-338.0K$1.1M$3.0M$8.2M$9.7M$3.5M$263.0K$263.0K
Depreciation & Amortization
$218.4K$156.0K$-338.0K$1.1M$3.0M$8.2M$9.7M$3.5M$263.0K$263.0K
Amortization
$218.4K$156.0K--$1.1M$3.0M$8.2M$9.7M$3.5M$263.0K$263.0K
Other Operating Expenses
$-374.4K----$612.0K$-60.0K$-159.0K--------
OPERATING INCOME
Operating income
$-5.1M$-12.2M$-16.1M$-220.0K$-5.6M$-35.2M$-145.5M$-23.4M$-4.5M$-16.6M
EBITDA
$-7.5M$-2.0M$3.5M$-1.4M$4.5M$-17.8M$-128.3M$-9.9M$-3.2M$-12.5M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$100.0K$190.0K$5.0K$5.0K------$1.4M$766.0K$-2.7M
Intinc
--$-109.0K$281.0K$501.0K$58.0K$-485.0K$-687.0K------
Net Non-Operating Interest Income/Expense
$-100.0K$-299.0K$276.0K$501.0K$58.0K$-485.0K$-687.0K$-1.4M$-766.0K$2.7M
Gain on Sale of Securities
$-2.8M------$1.3M--$697.0K--$-4.1M--
Other Income/Expense
$2.9M$-10.0M$9.2M$3.5M$-3.3M$-3.7M$-104.2M$-3.5M$3.6M$-1.8M
Other Special Charges
$2.4K$11.0M$-8.5M$-12.8M$3.6M$168.0K$704.0K$1.3M$494.0K$1.8M
SPECIAL ITEMS
Restructring And Mn A Income
$-100.0K--$3.4M$3.2M------------
Special Income Charges
$100.0K--$-3.4M$-3.2M----$-110.4M$-15.5M----
Impairment of Capital Assets
------------$110.4M$15.5M----
PRE-TAX INCOME
EBIT
$-7.9M$-2.4M$3.3M$-3.2M$-597.0K$-30.6M$-144.8M$-17.0M$-8.3M$-14.8M
Pre-Tax Income
$-8.0M$-2.5M$-25.0M$-3.2M$-597.0K$-29.0M$-144.8M$-18.5M$-8.8M$-12.1M
INCOME TAX
Tax Provision
$-900.9M$-5.4M--$-1.5M$-3.3M$-20.1M$-5.0M$-24.0K$-38.0K$49.0K
NET INCOME
Net Income
$-6.9M$-2.5M$-25.0M$-1.7M$2.0M$-8.9M$-139.8M$-68.0M$-20.2M$-4.6M
Net Income (Continuing Operations)
$-6.9M$-2.5M$-25.0M$-1.7M$2.7M$-8.9M$-139.8M$-18.4M$-9.0M$-12.1M
Net Income (Discontinued Operations)
$-6.9M$-2.5M$-25.0M$-1.7M$2.0M$-8.9M$-139.8M$-68.0M$-20.2M$-4.6M
Net Income (Common Stockholders)
$-6.9M$-2.7M$-25.3M$-1.7M$2.0M$-8.9M$-139.8M$-68.0M$-20.2M$-4.6M
Normalized Income
------$-13.9M$-1.6M--------$-12.0M
TOTALS
Total Expenses
$-13.1M$-12.1M$3.6M$27.1M$52.1M$139.0M$201.7M$71.6M$79.1M$97.3M
SHARE & EPS DATA
Average Shares Outstanding
$12.6M$13.3M$16.3M$19.5M$27.3M$38.5M$42.5M$43.7M$46.1M$47.8M
Average Shares Outstanding (Diluted)
$12.7M$12.0M$21.6M$19.5M$27.3M$38.5M$42.5M$43.7M$46.1M$48.6M
Shares Outstanding
$13.0M$14.1M$18.7M$24.0M$33.4M$42.1M$43.2M$45.3M$47.0M$48.3M
Basic EPS
----$0.18$-0.09$0.09$-0.20$-3.29$-1.52$-0.88$-0.09
Basic EPS (Continuing Operations)
------$-0.09$0.09$-0.20$-3.29$-1.52$-0.69$-0.25
Diluted EPS
$-0.54$-0.21$0.14$-0.09$-0.03$-0.20$-3.29$-1.52$-0.88$-0.10
Diluted EPS (Continuing Operations)
--------$-0.03$-0.20$-3.29$-1.52$-0.69$-0.25
OTHER METRICS
Accrued Preferred Stock Dividends
--$213.0K$339.0K$1.7M$954.0K$8.9M$139.8M$66.4M----
Acquisition Expense
------$940.0K$668.0K$1.6M$18.0K------
Basic Discontinuous Operations
----------------$-0.19$0.16
Diluted Discontinuous Operations
----------------$-0.19$0.15
Earnings from equity interest
--$-1.0M$-672.0K$-739.0K------------
Earnings From Equity Interest Net Of Tax
--$-1.0M$-672.0K$-739.0K------------
Gain On Sale Of P P E
$-1.2K------------------
Gains Loss On Disposal Of Discontinued Operations
--------------$-193.0K$132.0K--
Interest Expense Operating
--$-38.0K$-5.0K--------------
Minority Interests
$1.2M------------------
Net Income Discontinuous Operations
--------------$-49.6M$-11.1M$7.5M
Other Gain Loss From Disposition Of Discontinued Operations
--------------$-49.4M$-11.3M$7.5M
Other Gand A
$4.6M$4.5M$6.0M$8.9M$14.6M$33.7M$47.7M$43.3M$40.6M$45.5M
Other Write Down
$86.7K$108.7K----------------
Preferred Stock Dividends
--$213.0K$339.0K$1.7M$954.0K$8.9M$139.8M$66.4M----
Rent And Landing Fees
$4.6M$4.5M$6.0M--------------
Selling Expense
$3.0M$2.1M$2.6M--------------
Restruct
$-100.0K--$3.4M$3.2M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BLFS$25.25+3.1%540.99K
3
4
5
6

Get BioLife Solutions Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.